Goranov, S., Goranova-Marinova, V. Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma,
, 2005, 11-19.
Goranov, S., Goranova-Marinova, V. .
Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma.
Plovdiv: , 2005, 11-19.
Goranov, S., Goranova-Marinova, V. (2005)
Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma,
Plovdiv: , 11-19
Goranov, S., & Goranova-Marinova, V.
(2005).
Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma. Folia Medica. Plovdiv: 47 (3-4), 11-19.